PIII logo

P3 Health Partners (PIII)

Profile

Full Name

P3 Health Partners Inc.

Ticker Symbol

PIII

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Care Facilities

Country

United States

IPO

April 6, 2021

Indexes

Not included

Website

http://p3hp.org

Employees

360

Key Details

Price

$9.79(+8.90%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$1.50B(+18.48% YoY)

Annual EPS

-$1.08(-71.43% YoY)

PE ratio

-

Next earnings date

May 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$9.79
PIII price is $9.79

30-Day Relative Volume

-
PIII 30-day relative volume value is unknown

Price Performance

Price Most recent change

+8.9%
PIII price was up +8.9% on Apr 15, 2025

Price YTD change

-12.98%
PIII price is down -12.98% since January 1st

Price 1-year change

-58.52%
PIII price is down -58.52% year-on-year

Price 3-year change

-97.36%
PIII price is down -97.36% over the past 3 years

Price Range

Price All-time high

$572.00
PIII price is currently -98.29% below its historical high of $572.00

Price 3-year low

$0.15
PIII price is currently +6340.79% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$31.95M
PIII market capitalization is $31.95 million

Market cap 3-year change

-89.66%
PIII market capitalization is down -89.66% over the past 3 years

Market cap All-time high

$594.03M
PIII market capitalization is currently -94.62% below its historical high of $594.03 million

Market cap sector rank

32.32%
PIII market capitalization is higher than 32.32% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+36.64%
PIII shares outstanding is up +36.64% year-on-year

Shares Outstanding 3-Year Change

+292.4%
PIII shares outstanding is up +292.4% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.70
PIII beta is 0.70

200-day SMA

$16.67
PIII price is currently -41.28% below its 200-day simple moving average

50-day SMA

$9.34
PIII price is currently +4.82% above its 50-day simple moving average

RSI

57.83
PIII 14-day relative strength index is 57.83

Volume

-
PIII 30-day relative volume value is unknown

ATR

$3.51
PIII average true range is $3.51

10-day Historical Volatility

126.45%
PIII 10-day historical volatility is 126.45%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$1.50B
PIII annual revenue is $1.50 billion

Revenue Analysts estimate

$1.41B
PIII annual revenue is currently +6.41% higher than the consensus analysts' forecast

Revenue 1-year change

+18.48%
PIII annual revenue is up +18.48% year-on-year

Revenue Sector rank

83.35%
PIII annual revenue is higher than 83.35% of companies in Healthcare sector

EPS

EPS

-$1.08
PIII annual earnings per share is -$1.08

EPS Analysts estimate

-
PIII annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

-71.43%
PIII annual earnings per share is down -71.43% year-on-year

EPS Sector rank

54.85%
PIII annual earnings per share is higher than 54.85% of companies in Healthcare sector

Profit

Gross profit

-
PIII annual gross profit value is unknown

Gross margin

-
PIII annual gross profit margin value is unknown

Operating profit

-$312.60M
PIII annual operating income is -$312.60 million

Operating margin

-20.83%
PIII annual operating profit margin is -20.83%

Net income

-$135.85M
PIII annual net profit is -$135.85 million

Net margin

-9.05%
PIII annual net profit margin is -9.05%

Expenses

Total expenses

$1.81B
PIII annual total expenses is $1.81 billion

Operating expenses

$1.81B
PIII annual total operating expenses is $1.81 billion

Cost of goods sold

-
PIII annual cost of goods sold value is unknown

Selling, general & administrative expenses

$113.93M
PIII annual SGA is $113.93 million

Depreciation and amortization

$86.06M
PIII annual depreciation & amortization is $86.06 million

Interest expense

$22.17M
PIII annual interest expense is $22.17 million

Income tax

$4.39M
PIII annual income tax is $4.39 million

EBIT & EBITDA

EBIT

-$283.82M
PIII annual earnings before interest & taxes is -$283.82 million

EBITDA

-$197.76M
PIII annual EBITDA is -$197.76 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$783.42M
PIII annual total assets is $783.42 million

Non current assets

$599.28M
PIII annual long term assets is $599.28 million

Current assets

$184.14M
PIII annual total current assets is $184.14 million

Cash and cash equivalents

$38.82M
PIII annual cash & cash equivalents is $38.82 million

Accounts receivable

$121.27M
PIII annual accounts receivable is $121.27 million

Inventory

-
PIII annual inventory value is unknown

Liabilities

Total liabilities

$633.89M
PIII annual total liabilities is $633.89 million

Long term liabilities

$137.48M
PIII annual total long term liabilities is $137.48 million

Current liabilities

$496.42M
PIII annual total current liabilities is $496.42 million

Accounts payable

$64.01M
PIII annual accounts payable is $64.01 million

Debt

Total debt

$166.16M
PIII annual total debt is $166.16 million

Total debt 1-year change

+36.27%
PIII annual total debt is up +36.27% year-on-year

Long term debt

$101.16M
PIII annual long term debt is $101.16 million

Short term debt

$65.00M
PIII annual short term debt is $65.00 million

Equity & Capital

Shareholders equity

$75.94M
PIII annual stockholders equity is $75.94 million

Book value

$75.94M
PIII annual book value is $75.94 million

Retained earnings

-$503.19M
PIII annual retained earnings is -$503.19 million

Working capital

-$312.27M
PIII annual working capital is -$312.27 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$110.13M
PIII annual cash flow from operations is -$110.13 million

Cash from operations 1-year change

-44.85%
PIII annual cash flow from operations is down -44.85% year-on-year

Cash from investing

$14.53M
PIII annual cash flow from investing activities is $14.53 million

Cash from investing 1-year change

+895.02%
PIII annual cash flow from investing activities is up +895.02% year-on-year

Cash from financing

$98.77M
PIII annual cash flow from financing activities is $98.77 million

Cash from financing 1-year change

-1.56%
PIII annual cash flow from financing activities is down -1.56% year-on-year

CAPEX

CAPEX

-
PIII annual capital expenditures value is unknown

CAPEX 1-year change

-
PIII annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$110.13M
PIII annual free cash flow is -$110.13 million

Free cash flow 1-year change

-41.45%
PIII annual free cash flow is down -41.45% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
PIII annual gross profit margin value is unknown

Operating margin

-20.83%
PIII annual operating profit margin is -20.83%

Net margin

-9.05%
PIII annual net profit margin is -9.05%

ROA & ROE

ROA

-16.52%
PIII annual return on assets is -16.52%

ROE

-46.59%
PIII annual return on equity is -46.59%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
PIII price to earnings ratio value is unknown

PE ratio Sector rank

-
PIII price to earnings ratio is unknown

PB Ratio

PB ratio

0.42
PIII price to book ratio is 0.42

PB ratio Sector rank

27.33%
PIII price to book ratio is higher than 27.33% of companies in Healthcare sector

PS Ratio

PS ratio

0.02
PIII price to sales ratio is 0.02

PS ratio Sector rank

2.44%
PIII price to sales ratio is higher than 2.44% of companies in Healthcare sector

Enterprise value

Enterprise value

$159.29M
PIII enterprise value is $159.29 million

Enterprise value Sector rank

55.42%
PIII enterprise value is higher than 55.42% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.81
PIII EV/EBITDA is -0.81

EV/EBITDA Sector rank

46.3%
PIII EV/EBITDA is higher than 46.3% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

0.37
PIII annual current ratio is 0.37

Quick ratio

-
PIII annual quick ratio value is unknown

Leverage

Debt to equity

2.04
PIII annual debt to equity ratio is 2.04

Interest coverage ratio

-12.80
PIII annual interest coverage ratio is -12.80

Risk & Stability

Piotroski F-Score

-
PIII piotroski f-score value is unknown

Altman Z-Score

-0.63
PIII altman z-score is -0.63

Analyst ratings

Recent major analysts updates

Nov 20, 24 TD Cowen
Hold
Apr 1, 24 BTIG
Neutral
Mar 14, 24 Lake Street
Buy
Sep 1, 23 BTIG
Buy
Jun 30, 23 TD Cowen
Market Perform
Jan 4, 22 William Blair
Outperform

Institutional Ownership

Similar stocks

LSB logo
LakeShore Biopharma Co Ltd (LSB)
Spectral AI (MDAI)
OS Therapies Incorporated (OSTX)
FEMY logo
Femasys (FEMY)
RNXT logo
RenovoRx (RNXT)
CASI logo
CASI Pharmaceuticals (CASI)
ESLA logo
Estrella Immunopharma (ESLA)
INKT logo
MiNK Therapeutics (INKT)
Cadrenal Therapeutics (CVKD)
  • What is the ticker symbol for P3 Health Partners?
  • Does P3 Health Partners pay dividends?
  • What sector is P3 Health Partners in?
  • What industry is P3 Health Partners in?
  • What country is P3 Health Partners based in?
  • When did P3 Health Partners go public?
  • Is P3 Health Partners in the S&P 500?
  • Is P3 Health Partners in the NASDAQ 100?
  • Is P3 Health Partners in the Dow Jones?
  • When was P3 Health Partners's last earnings report?
  • When does P3 Health Partners report earnings?
  • Should I buy P3 Health Partners stock now?

What is the ticker symbol for P3 Health Partners?

The ticker symbol for P3 Health Partners is NASDAQ:PIII

Does P3 Health Partners pay dividends?

No, P3 Health Partners does not pay dividends

What sector is P3 Health Partners in?

P3 Health Partners is in the Healthcare sector

What industry is P3 Health Partners in?

P3 Health Partners is in the Medical Care Facilities industry

What country is P3 Health Partners based in?

P3 Health Partners is headquartered in United States

When did P3 Health Partners go public?

P3 Health Partners's initial public offering (IPO) was on April 6, 2021

Is P3 Health Partners in the S&P 500?

No, P3 Health Partners is not included in the S&P 500 index

Is P3 Health Partners in the NASDAQ 100?

No, P3 Health Partners is not included in the NASDAQ 100 index

Is P3 Health Partners in the Dow Jones?

No, P3 Health Partners is not included in the Dow Jones index

When was P3 Health Partners's last earnings report?

P3 Health Partners's most recent earnings report was on Mar 27, 2025

When does P3 Health Partners report earnings?

The next expected earnings date for P3 Health Partners is May 8, 2025

Should I buy P3 Health Partners stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page